Literature DB >> 12805456

Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.

Laura Hertel1, Vashti G Lacaille, Herbert Strobl, Elizabeth D Mellins, Edward S Mocarski.   

Abstract

Human cytomegalovirus (CMV) infection initiates in mucosal epithelia and disseminates via leukocytes throughout the body. Langerhans cells (LCs), the immature dendritic cells (DCs) that reside in epithelial tissues, are among the first cells to encounter virus and may play important roles in the immune response, as well as in pathogenesis as hosts for viral replication and as vehicles for dissemination. Here, we demonstrate that CD34(+) progenitor cell-derived LC-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection. In contrast to the small percentage (3 to 4%) of the immature LCs that supported infection, a high percentage (48 to 74%) of mature, LC-derived DCs were susceptible to infection with endotheliotropic strains (TB40/E or VHL/E) of CMV. These cells were much less susceptible to viral strains AD169varATCC, TownevarRIT(3), and Toledo. When exposed to endotheliotropic strains, viral gene expression (IE1/IE2 and other viral gene products) and viral replication proceeded efficiently in LC-derived mature DCs (mDCs). Productive infection was associated with downmodulation of cell surface CD83, CD1a, CD80, CD86, ICAM-1, major histocompatibility complex (MHC) class I, and MHC class II on these cells. In addition, the T-cell proliferative response to allogeneic LC-derived mDCs was attenuated when CMV-infected cultures were used as stimulators. This investigation revealed important characteristics of the interaction between CMV and the LC lineage of DCs, suggesting that LC-derived mDCs are important to viral pathogenesis and immunity through their increased susceptibility to virus replication and virus-mediated immune escape.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805456      PMCID: PMC164783          DOI: 10.1128/jvi.77.13.7563-7574.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

Review 1.  In vivo maturation and migration of dendritic cells.

Authors:  L Flores-Romo
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 2.  How dendritic cells and microbes interact to elicit or subvert protective immune responses.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

Review 3.  Epidermal Langerhans cell development and differentiation.

Authors:  H Strobl; E Riedl; C Bello-Fernandez; W Knapp
Journal:  Immunobiology       Date:  1998-03       Impact factor: 3.144

4.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; I Durand; M Cella; A Lanzavecchia; J Banchereau
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

5.  Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

Authors:  S Riegler; H Hebart; H Einsele; P Brossart; G Jahn; C Sinzger
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

6.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

Authors:  K Kondo; H Kaneshima; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.

Authors:  Géraldine Arrode; Claire Boccaccio; Jean-Pierre Abastado; Christian Davrinche
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Authors:  Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Growth of human cytomegalovirus in primary macrophages.

Authors:  C Söderberg-Nauclér; K N Fish; J A Nelson
Journal:  Methods       Date:  1998-09       Impact factor: 3.608

10.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

Authors:  M Mendelson; S Monard; P Sissons; J Sinclair
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

View more
  66 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

2.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

3.  B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Authors:  Ramon Arens; Andrea Loewendorf; Min J Her; Kirsten Schneider-Ohrum; Geoffrey R Shellam; Edith Janssen; Carl F Ware; Stephen P Schoenberger; Chris A Benedict
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 4.  Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Authors:  Emmanuel J Wiertz; Robert Devlin; Helen L Collins; Maaike E Ressing
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 5.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

6.  Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton.

Authors:  Matthew S Miller; Laura Hertel
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

7.  Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Authors:  Ying-Liang Duan; Han-Qing Ye; Anamaria G Zavala; Cui-Qing Yang; Ling-Feng Miao; Bi-Shi Fu; Keun Seok Seo; Christian Davrinche; Min-Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

8.  Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Authors:  Andrea M Fox-Canale; Thomas J Hope; Jeffrey Martinson; John R Lurain; Alfred W Rademaker; James W Bremer; Alan Landay; Gregory T Spear; Nell S Lurain
Journal:  Virology       Date:  2007-08-22       Impact factor: 3.616

9.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  Inhibition of CD1 antigen presentation by human cytomegalovirus.

Authors:  Martin J Raftery; Manuel Hitzler; Florian Winau; Thomas Giese; Bodo Plachter; Stefan H E Kaufmann; Günther Schönrich
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.